Pharma Expert | Wide-ranging expertise

Mariann Lassenius

Sr. Scientific Advisor

RWE Lead

PhD

+358 50 345 2393
mariann.lassenius@medaffcon.fi

Mariann joined Medaffcon’s team in 2016 after finishing her PhD. The transition to real world evidence (RWE) research was a natural continuum to her previous research career. Through RWE studies, she has had the privilege to gain a broad insight into working with different stakeholders within the healthcare field. The vast proportion of her days goes towards interacting with clients, planning and performing RWE studies, and supporting Medaffcon’s RWE team. Subjects that keep her work interesting are the vast variability of customers and projects, problem-solving, and interacting with people.

“The number of RWE studies has increased since stakeholders within the healthcare industry have an increasing demand for knowledge-based decision making tools that need to be fulfilled. The future, therefore, has an ever-increasing emphasis on RWE”.

Kristiina Pelli

Sr. Scientific Project Manager

Medical Affairs Lead

MSc (Food Science), MBA

+358 40 510 0838
kristiina.pelli@medaffcon.fi

Linkedin-profiili

Kristiina joined Medaffcon as a Business development manager in 2012. She started her career in a CRO, after which she worked in scientific advisor and line manager positions in two large pharmaceutical organizations, now reaching already 15 years in the business. Kristiina holds master’s degrees in both Nature Sciences and Business (Henley MBA).

At Medaffcon, nowadays as a Medical Affairs team lead, Kristiina leverages her long experience from various stakeholders in the business and her vast therapeutic area expertise in close collaboration with her team to the benefit of customer assignments. When asking what the best part of this work is, she refers to the fast change and the continuous strive for the better, for all of us, as health care service utilizers. ”Every year, I feel that never before have we been working on such vast and important topics and yet, next year the feeling is the same again”.

Liisa Ukkola-Vuoti

Sr. Scientific Advisor

PhD

liisa.ukkola-vuoti@medaffcon.fi

Linkedin-profiili

Liisa joined Medaffcon in January 2020. She has over ten years of experience of working as a scientific advisor and research scientist for private and public sector organizations. Liisa holds a PhD in medical genetics, and she mentions that especially the therapeutic areas related neurology and psychiatry appeal to her.

Liisa’s strengths include strong expertise on medical sciences and research, as well as on creating evidence-based content, because she also has experience of being a science book author. Establishing cross-scientific collaboration, scientific exchange, and creating networks are one of her key work philosophies.

One of her main professional interests is the secondary use of health-related data to create real-world-evidence in order to improve and develop treatment practices. ”Due to the unique registries and data lakes available in Finland, in principle all the required data is already available or accumulating all the time, which makes it important to utilize this real-world-data to improve patient care and general well-being.”

Kristiina Uusi-Rauva

Sr. Scientific Advisor

PhD

kristiina.uusi-rauva@medaffcon.fi

Linkedin-profiili

Kristiina joined Medaffcon’s RWE team in the fall of 2019. She holds a PhD and her doctoral dissertation concentrated on cell biology of a rare neurological disease. After defending her PhD, Kristiina worked on projects using iPS cell technology in several different research groups for rare diseases. In addition, she has experience in the most common diseases, as she has worked with diabetic research, for example.

“In this work, we can see from the field how know-how is effectively acquired and for what purposes it is used in healthcare. I look forward to seeing the full potential of biobank sample collections for future use in RWE research, including rare diseases”.

Kai Kysenius

Scientific Advisor

PhD

kai.kysenius@medaffcon.fi

Linkedin-profiili

Kai joined Medaffcon in September 2020 after five years of Post doctorate studies in Australia. In his PhD thesis, Kai studied the role of lipoprotein receptors in neuronal cell death and continued his studies on deciphering the mechanisms and testing potential therapeutics for neurodegenerative diseases at the University of Melbourne. Kai completed his university degrees at the University of Helsinki and the Neuroscience Center, which included one semester exchange at the Victoria University of Wellington, New Zealand.

Due to his international educational background, Kai’s strengths include his adept ability to work in multicultural settings and cross disciplinary projects. Kai is fascinated by out-of-the-box scientific projects and how they emerge to challenge existing norms. “Data driven decision making, critical but constructive discussion and multifaceted cooperation can ensure a functional and healthy society in the face of future challenges. Together we are stronger and wiser.”

Bettina Mannerström

Scientific Advisor

PhD

bettina.mannerstrom@medaffcon.fi

Linkedin-profiili

Bettina joined Medaffcon in February 2021. She has more than 15 years of experience of scientific work, in which the clinical applicability has always been in focus. Before joining Medaffcon, Bettina held the position of senior researcher at University of Helsinki. Bettina received her MSc degree from Åbo Akademi University during which she spent a year at University of Victoria, Canada. She received her PhD in tissue engineering from University of Tampere. As a result of a long career in science, Bettina also has a title of docent in Cell Biology.

Bettina has a strong background in cross disciplinary projects, working in multicultural teams and a solid interest in collaboration with health care professionals. Multidisciplinary projects where the knowledge of various experts is utilized for improved patient care are close to heart. In Medaffcon, Bettina is fueled by working with, sharing and applying scientific knowledge for advancing healthcare.

Riikka Mattila

Scientific Advisor

PhD

riikka.mattila@medaffcon.fi

Linkedin-profiili

Riikka joined Medaffcon in February 2021. She has a wide-ranging experience from different therapy areas from atherosclerosis and birth asphyxia to neurodegeneration. She has more than 15 years of experience in research, three of which in Max Planck Institute in Germany. Her PhD thesis from 2011 focused on cholesterol metabolism.

Riikka’s strenghts include broad know-how and interest in diverse therapy areas, as well as enthusiasm and experience in both written and verbal scientific communication. At Medaffcon she enjoys varied projects and effectiveness of research.

Real world evidence fascinates Riikka because there is so much data, and more accumulating all the time, and most of this data is unused. There is potential for findings to support clinicians and the pharmaceutical industry, as well as alleviate the lives of patients. She is also happy that decisions in health care are increasingly evidence based.

Outi Laatikainen

Scientific Advisor

PhD

outi.laatikainen@medaffcon.fi

Linkedin-profiili

Outi joined the Medaffcon team in February 2022. Outi has a master’s degree in Pharmacy, but for the most of her career she has been working as a clinical researcher in specialized care. Her previous research is from the field of clinical pharmacology. In 2020, Outi’s PhD on medication-related adverse events in specialized care was published at the University of Oulu. Among clinical research, Outi has gained experience also as a clinical pharmacist in specialized care.

The general knowledge of clinical pharmacology and the medication processes in health care are one of the strongest assets of Outi in RWE research. Outi is especially interested in rational medication and population-wide effectiveness studies on pharmacotherapies. Outi is also interested in AI methods and their use in improving the safety and efficacy of pharmacotherapies via personalized medication in the future. Outi considers her enthusiasm for pharmacology development as one of her best aspects.

Essi Havula

Scientific Advisor

PhD

essi.havula@medaffcon.fi

Linkedin-profiili

Essi joined Medaffcon in September 2023. Essi holds a PhD in biosciences and in her thesis she studied the genetics of sugar metabolism. After completing her pre- and postgraduate studies at the University of Helsinki, she transferred internationally to continue to study gene-diet interactions at the University of Sydney. Spanning over 15 years, Essi’s scientific career includes research in numerous fields including breast cancer and mitochondrial diseases.

Essi’s strengths include broad scientific and international background with special interests in personalized medicine, metabolic diseases and science popularization. At Medaffcon, Essi is particularly motivated by the utilization and communication of RWE studies to support better decision-making in our patient care and more broadly for our healthcare sector.

“Data driven decision making requires us as experts to process and communicate the vast amounts of data into a form that is accessible to all healthcare authorities. I’m looking forward to seeing how RWE studies can guide the development of personalized therapy solutions, that are not only economically the most efficient, but benefit the patients in the best possible manner.”

Johan Rehnberg

Scientific Advisor

PhD

johan.rehnberg@medaffcon.se

Linkedin-profiili

Johan joined Medaffcon in August 2024. He holds a PhD in Public Health and in 2023 he completed a four-year postdoctoral research position at Karolinska Institutet, where he led an international research project in collaboration with researchers from Amsterdam University Medical Center (UMC).

In 2023, Johan transitioned from academia to a role as a medical assessor at the Swedish Dental and Pharmaceutical Benefits Agency (TLV), where he gained valuable insights into the processes involved in bringing pharmaceutical products to the Swedish market.

Johan’s strengths lie in his decade-long research experience within multidisciplinary environments at both Karolinska Institutet and Stockholm University. He has extensive experience working with Swedish and Nordic health register data, which, combined with his regulatory knowledge from TLV, makes him well-equipped for planning and conducting RWE studies in Sweden.

“I am excited to continue leveraging the high-quality health registers available in the Nordics to generate valuable insights. These insights will empower patients, healthcare providers, and pharmaceutical companies to make more informed, evidence-based decisions.”

Tanja Nieminen

Health Economist & Scientific Project Manager

MSc (Health Economics & Economics)

Linkedin-profiili

Tanja joined Medaffcon’s team in November 2016. Before that, she worked as a researcher at the National Institute for Health and Welfare. Tanja has also worked in an international research group, as a course instructor as well as in financial administration and customer service. She holds MSc degrees in both Health Economics and in the field of Economics and Business Administration.

Tanja’s strengths include her educational and occupational background in health economics from Finland and abroad. Tanja has a special interest in utilizing real-world evidence data to be used in evaluations. “By utilizing data resources to support decision-making we become more aware of how scarce resources should be allocated”.

Timo Karvinen

Market Access Specialist & Analyst

MSc (Food Science)

timo.karvinen@medaffcon.fi

Linkedin-profiili

Timo started at Medaffcon in May 2023, bringing his experience and know-how e.g. about developing and utilizing analyses. Timo’s long experience in pharma industry in analytics, marketing and sales gives him a good understanding of the operation of pharmaceutical companies. Timo holds a MSc in Food Economics and Marketing. Market Access and Health economic analyses are new development areas for Timo. In his previous role Timo developed analytical services for pharmaceutical companies.

Timo is inspired about supporting and helping decision making with data. “Data provides a solid foundation for decisions. Data acquired and analyses carried out should be grounded on the decisions made based on them.” Developing new things and overcoming challenges gives Timo energy at work.

Timo believes, that in the future data will be collected and combined from more sources than before. Evaluating effectiveness will be important in decision making in health care and more comprehensive health economic analyses will be needed.

Juulia Tuominen

Maternity leave

Market Access Specialist

MSc (Tech.)

Linkedin-profiili

Juulia started working at Medaffcon in early June. Before moving to Medaffcon, Juulia worked as a researcher in a company developing PCR-based molecular diagnostic products for infectious diseases. Juulia has also worked in the pharmaceutical industry in the quality and regulatory team and in the academic research group of canine genetics as an assistant roles. By education, Juulia has a Master’s degree in Chemical engineering from Aalto University, majoring in biotechnology. Juulia completed her bachelor’s degree at the University of Helsinki. In her diploma thesis, she developed the genetic engineering tools for the microbes at VTT to function as a production host organism. Such production host organisms are used, for example, in the production of drug molecules. Before moving to the world of natural sciences, Juulia worked five years as a benefits officer in an environment where changing legislation was everyday life.

Juulia brings open-mindedness to Medaffcon and experiences from other environments, outside the traditional pharmaceutical industry. Her strength is also understanding the science on a biochemical level behind data and products. Years as a product developer have taught her creativity, problem-solving skills and the belief that not everything has been solved yet. Juulia is interested in Market Access functions and its possibilities to influence society, without forgetting the science behind every reimbursement decision.

“Although the pharmaceutical industry has been considered a traditional field where the changes happen slowly, the world has changed and the winds of change are also blowing faster in the pharmaceutical industry. I believe that, personalized medicines will become more common based on individual genomics and the possibility of gene therapy and stem cell treatments will expand to greater therapeutic use. Unfortunately, the availability of new technologies is slowed down by the price .”

Lotta Jokimies

Jr. Market Access Specialist

MSc (Tech.)

lotta.jokimies@medaffcon.fi

Linkedin-profiili

Lotta joined Medaffcon in January 2024 and started as an intern in the Market Access team. Lotta is a registered nurse (AMK) and has a master’s degree in health sciences, majoring in health economics. Lotta has completed her master’s degree in health sciences at the University of Eastern Finland. In addition, Lotta has published the article “Cost effects of municipal total outsourcing: an analysis based on register data” in the Journal of Social Medicine. Lotta has previously worked in health care and has worked as a nurse and health nurse in the public and private sector, both in primary health care and in specialized nursing care. Lotta has experience in clinical work in health care, both in children’s and adults’ medical care, as well as in preventive health care. Before moving to Medaffcon, Lotta worked as an expert in competence development in the social health and rescue industry.

At Medaffcon, Lotta works with Market Access functions and is very interested in work related to pharmaceuticals and healthcare. Lotta is also interested in issues related to people’s well-being and health and doing meaningful work.

Lotta brings experience and know how related to the social and health care sector to the team. Lotta knows the social and health service system and related legislation. In addition, Lotta has a strong knowledge of various diseases and the medicines used to treat them. Lotta also understands the importance of health promotion and disease prevention in society.

Annu Söderholm

Market Access Manager

PhD

annu.soderholm@medaffcon.fi

Annu joined the Market Access team at Medaffcon in the spring of 2024, bringing with her over 15 years of work experience in the pharma industry. Before joining Medaffcon, she worked in pharmaceutical and consultancy companies in various roles within clinical trials, pharmacovigilance, and market access functions. Annu holds a PhD in biochemistry and in her thesis she studied protein-ligand interactions using computer-aided drug design methods.

Annu considers her science background and versatile pharmaceutical expertise as strengths that she can utilize in her everyday work in the role of Market Access Manager at Medaffcon. She has experience of pricing and reimbursement processes of pharmaceuticals from various therapeutic areas and different stages of lifecycle. What drives Annu in market access role is the purpose of the work. “Contributing to the process of ensuring patient access to new and effective medical treatments feels meaningful”.

Katariina Autio

Jr. Health Economist

MSc (Health Economics)

katariina.autio@medaffcon.fi

Linkedin-profiili

Katariina joined Medaffcon’s Health Economics and Market Access team in April 2024. She has a Master’s degree in Health Sciences with a major in Health Economics and a minor in Pharmacoeconomics. She has bachelor degrees of public health and nursing and almost 10 years of experience in primary healthcare and special health care. Before Medaffcon, she worked in a pharmaceutical company in the Vaccines and Market Access teams. Katariina’s knowledge of healthcare gives her a broad understanding of different therapy areas and treatment paths. In her work, the public health perspective is combined with a patient-centered approach, creating sustainable solutions for comprehensive health technology assesment.

Katariina is motivated by the innovative and rapidly evolving environment of the pharmaceutical industry and especially the localization of health economic models. She brings to Medaffcon analytical skills, brightness and versatile language skills. “The change of mindset towards value-based healthcare combined with the production and utilization of real-world data, opens up innovative ways to develop healthcare in a new direction. I believe that a decade of effectiveness will significantly shape the industry in a new direction.”

Simo Jääskeläinen

Market Access Lead

MSc (Health Sciences), BBA

Simo started as the leader of Medaffcon’s Market Access team in November 2024. He is a returnee, as he has also previously worked at Medaffcon. Before returning to Medaffcon, Simo worked in a pharmaceutical company as the head of a Market Access team and has also gained Market Access experience in other pharmaceutical companies. He has over 20 years of experience in the pharmaceutical industry. Simo holds a Master’s degree in Health Sciences and a Bachelor’s degree in Business Administration.

Simo brings to Medaffcon a strong and versatile background in the pharmaceutical industry, particularly in Market Access roles. His strengths include versatility, organizational skills, and the ability to see the bigger picture. In the field of Market Access, Simo does not consider himself an expert in any particular subfield but sees himself as a generalist. He is drawn to the challenges of the industry and the opportunity to find comprehensive solutions that meet the needs of clients.

Ongoing changes in the operating environment require pharmaceutical companies to adapt and adopt new ways of working. Simo believes that the role and importance of Market Access will become even more prominent in a situation where society’s willingness to pay and the needs of the pharmaceutical industry must be aligned in a way that benefits both parties.

Julia Salmi

Health Economist

MSc (Health Economics)

Julia Salmi joined Medaffcon’s Market Access team as a Health Economist in November 2024. She has studied Health Economics at the University of Eastern Finland and is also a registered nurse and paramedic. Before joining Medaffcon, Julia gained experience in Market Access and Finance teams as an intern at an international pharmaceutical company and worked in Market Access teams at pharmaceutical consultancy firms in Stockholm, Sweden and Helsinki, Finland. She has extensive knowledge of the Finnish healthcare system, and the processes involved in pharmaceutical market access. Additionally, Julia worked as a paramedic at the Helsinki Rescue Department, which deepened her understanding of patient-centred healthcare.

Julia is passionate about applying her health economics expertise to support the market entry of new treatment options and enhance patient care.

“I find my work and expertise particularly meaningful in today’s world. On one hand, I see the ongoing development in the pharmaceutical industry and the creation of increasingly advanced, personalized treatment options for patients. On the other hand, we have limited resources, which must be used wisely.”

Iiro Toppila

Biostatistician

Data Analysis Lead

MSc (Tech.)

+358 44 314 1597
iiro.toppila@medaffcon.fi

Linkedin-profiili

Iiro joined Medaffcon in March 2017 as a Biostatistician. For the preceding four years, he has worked as a research assistant in an academic study group, analyzing clinical and genetic patient data. Iiro holds a Master of Science degree in Technology in Bioinformation Technology.

Iiro’s strengths include his strong expertise in statistics and data-analysis, hands-on experience in working with sensitive patient data, and strong interdisciplinary communication skills with experts from various fields. In the field, he is particularly interested in the large data amounts made available with the revolution of technology and how the information received such data can potentially be utilized to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment.

“Machine learning and AI-based solutions will have a major impact on the healthcare sector now and in the future. However, effectively utilizing the already collected and available health-data will have a higher importance in order to improve health-care”.

Samuli Tuominen

Sr. Data Scientist

Data Scientist

MSc (Statistics)

samuli.tuominen@medaffcon.fi

Linkedin-profiili

Samuli joined Medaffcon in November 2018. He acquired a master’s degree in Statistics at the University of Helsinki, specializing in Bioinformatics in September 2018. Before joining Medaffcon, Samuli had two years’ worth of experience in research as a research assistant at the University of Helsinki, where he contributed to unraveling the genetic and epigenetic background of psychological characteristics (Depsy-group).

Samuli is especially interested in producing influential research data based on information on real-world patients. He is also interested in applying varying statistical and machine learning methods. Samuli has a broad theoretical and methodological understanding, as well as experience in working with big data. He is a problem solver and has an analytical take on work.

“I see that the health sector is being transformed by digitalization. I am excited to further develop the new opportunities made possible by the automated collection of patient data”.

Johanna Vikkula

Sr. Data Scientist

MSc (Tech.)

johanna.vikkula@medaffcon.fi

Linkedin-profiili

Johanna joined Medaffcon on February 2020 just after finishing her masters’ degree at Aalto University with major in bioinformatics and digital health. Previously, Johanna has been working as a research assistant both in brain imagining and in computational systems biology while reinforcing her knowledge in signal processing, analyses of genetic data, artificial neural networks, and development of new methods and tools to analyse genetic data. Johanna possesses strong knowledge in analysing genetic data thanks to broad know-how in life sciences but also in data and computational sciences. Johanna is a solution-oriented team worker, who does not fear to set goals high.

Johanna is interested in enhancing healthcare through bioinformatics and data sciences by combining both the medical and the computational know-how to cure diseases, improve healthcare and take step towards more personalised healthcare.

“I eagerly wait how the genome sequencing and gene testing revolutionise the medical field and boost more personalised treatments. Also, I believe that one day, we will have artificial intelligence as a standard tool for aiding doctors to diagnose and treat patients.”

Juhani Aakko

Sr. Data Scientist

D.Sc. (Tech.)

juhani.aakko@medaffcon.fi

Linkedin-profiili

Juhani joined Medaffcon in October 2020 as a data scientist. Prior to joining Medaffcon, Juhani has worked as a data scientist in a global IT company as well as a scientist at the University of Turku in the Medical Bioinformatics Centre (MBC) and Functional Foods Forum (FFF). Juhani holds a Doctor of Science in Technology degree (2017) and the topic of his thesis was the development of human gut microbiota in early infancy.

Juhani has experience from applying statistical and machine learning methods in medicine and due to his multidisciplinary background, he can easily communicate with people with varied expertise ranging from clinicians to IT-professionals. “Knowledge management and business intelligence have become hot topics also in the social and healthcare sectors. It is very interesting to be involved in harnessing the vast amounts of data available in the systems to actual usable information to support decision making. Both traditional statistics as well as advanced analytics and artificial intelligence will be in a key role in this job.”

Olivia Hölsä

Data Scientist

MSc (Tech.)

olivia.holsa@medaffcon.fi

Linkedin-profiili

Olivia joined Medaffcon in 2021 as a trainee to work on her Master’s thesis. She is finishing her studies in bioinformatics and digital health at Aalto University and has also worked as teaching assistant alongside her studies there for three years. Her main strengths are analytical thinking, problem solving skills and proactive mindset.

She is interested in data analysis in the field of social and healthcare to support decision making in improving social and healthcare services and allocating their resources more effectively.

Anna Anttalainen

Data Scientist

MSc (Tech.)

anna.anttalainen@medaffcon.fi

Linkedin-profiili

Anna joined Medaffcon’s analytics team in the fall of 2021. She has a master’s degree in Bioinformation Technology from Aalto University, and her studies focused primarily on mathematical modeling and machine learning. She has worked at Aalto University’s Department of Neuroscience and Biomedical Engineering as a research assistant, as a teacher in a mathematical modeling course, and in the last years before Medaffcon as a data scientist in a startup developing a medical device.

Anna has a strong background in the application of statistics and especially machine learning methods to various datasets. Anna also has experience in conducting research, all the way from collecting data to analyzing the results and scientific writing. She is particularly interested in solving real-world problems faced by healthcare and medicine using mathematical modeling methods and artificial intelligence.

“The constantly increasing amount of health data, combined with the modern computational capacity and evolving modeling methods, create enormous potential for findings that could hardly be detected by purely manual examination.”

Sanaz Jamalzadeh

Data Scientist

PhD Candidate

sanaz.jamalzadeh@medaffcon.fi

Linkedin-profiili

Sanaz joined Medaffcon in September 2023 as a data scientist. She is finalizing her doctoral thesis in the field of Biomedicine at Faculty of Medicine, University of Helsinki. Her research focuses on characterizing resistance mechanisms in ovarian cancer through multi-omics data integration, clinical data analysis, and tissue microarray image analysis in collaboration with Turku University Hospital.

Prior to her doctoral pursuits, Sanaz worked as a research assistant in computational biology, collaborating with University of South Wales, Australia. Her professional journey has cultivated a diverse skill set including cancer research, bioinformatics, machine learning, and data science, making her an ideal collaborator for individuals from various disciplines.

“The emergence of novel statistical and machine learning approaches, coupled with the growing volume of health sector data has the potential to enhance every facet of the healthcare industry, from drug discovery and development to clinical trials and patient care. This signifies that we are in a precision medicine era where data-driven decisions drive innovation and efficacy.”

Heikki Koski

Managing Director

MSc (Tech.), B.Sc. (Econ.)

+358 44 251 7840
heikki.koski@medaffcon.fi

Linkedin-profiili

Heikki Koski started as the CEO of Medaffcon in April 2024. Prior to this role, he worked as the Director of Service Business and Development at Tamro and as a board member of Tamro’s subsidiary, Medaffcon, since 2020. As a board member, Koski collaborated with CEO Jarmo Hahl in developing Medaffcon’s business. Koski continues to serve as a member of Tamro’s executive team.

Koski has extensive experience in service business, as well as in leading and developing digital business. At Tamro, he has been responsible for data services, e-commerce and service platform MyTamro, the health technology service Smila and Tamro’s business development, strategy processes. Prior to Tamro, Koski held various leadership roles at Finavia, including Airport Director and Chief Digital Officer. He has also worked as a consultant, entrepreneur and in product management at Nokia. Koski holds a Master’s degree in Industrial Engineering and Management and has also studied finance at Aalto University.

At Medaffcon, Koski brings strong expertise in service and digital business management and development, including the establishment of operating models and processes for expert organizations, strategy implementation and development, and internationalization.

In Medaffcon and the healthcare sector, Koski is motivated by the meaningfulness of the work. “It is crucial for every individual that the most effective treatments are made available. Technology accelerates development in the field, both in drug development and in building new ways of working. The significance and potential of health data are immense – the utilization of health data in the development and evaluation of treatment methods is constantly growing.”

Jarmo Hahl

Principal Consultant

MSc (Economics)

+358 40 139 4001
jarmo.hahl@medaffcon.fi

Linkedin-profiili

Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.

Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.

“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.

Tomi Vahevaara

Sales Lead

eMBA

+358 50 305 5963
tomi.vahevaara@medaffcon.fi

Linkedin-profiili

Tomi Vahevaara started working at Medaffcon in January 2017 as a Sales Director. He has been working in the pharmaceutical industry for over 35 years. Therefore, he has gained wide-ranging experience in international expert and managerial positions within the innovative pharmaceutical industry. Before joining Medaffcon, Tomi worked for ten years as the Managing Director of Eli Lilly for Finland, the Baltic States, and Poland.

Tomi has solid and wide-ranging expertise in different positions in the pharmaceutical field and is well connected in the entire health industry network. He serves as the Chairman of the Board of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities and as a Board Member in the Finnish Co-operative for Pharmaceutical Injury Indemnities. Tomi is particularly interested in the significant economic and investment opportunities for Finland and those companies working in the Finnish health industry.

Petri Määttä

Sr. Consultant

BBA

+358 40 355 6111
petri.maatta@medaffcon.fi

Linkedin-profiili

Petri joined Medaffcon in 2022 as a consultant. Petri holds extensive experience in the pharmaceutical industry especially in Market Access, sales and marketing. Before joining Medaffcon Petri worked in various managerial roles in the pharmaceutical industry which has provided him with a comprehensive understanding of the challenges and opportunities in the field. Petri conducted his BBA studies in the Netherlands and Finland providing him with a great basis to work in international organizations.
Petri’s extensive experience in the pharmaceutical industry and his background in business equip him with a unique perspective in the field of Life Science and commercialization of medicines in Finland. His main focus is on helping companies bring Life Science innovations and services to the Finnish market. Petri’s expertise in Market Access, sales and marketing as well as his deep understanding of the pharmaceutical industry provide Medaffcon’s team with valuable information as they provide customer solutions.
“Resource challenges alongside technological development and digitalization provide considerable opportunities to enhance healthcare in Finland. As data collection and digitalization develop, the effectiveness of health technologies can be demonstrated more precisely. While advanced health technologies and medicine offer more effective treatments, bringing them to the market require special know-how and understanding. Thus, companies, the research sector and governmental agencies should continue to further co-operation in effectively bringing health technologies and medicines to the market while simultaneously managing resource allocation in a rational manner.”

Marissa Vahevaara

Sales & Admin Coordinator

BBA

+358 50 543 5995
marissa.vahevaara@medaffcon.fi

Linkedin-profiili

Marissa Vahevaara joined Medaffcon in March 2021 as a trainee and works as a sales support and assists in administrative tasks. She is studying business administration at Haaga-Helia with a focus on marketing and communications.

Marissa has always been interested in the well-being and health industry, as she feels her work has a tangible impact on the well-being of people and offers continuous learning opportunities. At Medaffcon, Marissa thinks that seeing the latest industry trends and requirements is especially attractive.

Tuuli Moilanen

Maternity Leave

Marketing Lead

BBA

Linkedin-profiili

Tuuli joined Medaffcon in May 2012 as an Assistant. She completed her Bachelor of Business Administration (International Business) degree in May 2015, after drafting her Bachelor’s Thesis for Medaffcon on the internationalisation practices of expert organisations. After graduation, Tuuli’s job description at Medaffcon has included, inter alia, financial administration and marketing tasks.

Since December 2015, Tuuli has worked as Marketing Lead, managing Medaffcon’s websites and social media presence, designing and implementing marketing activities and online content, and organizing Medaffcon’s events.

Lisse-Lotte Hermansson

Country Director Sweden

M.Sc (Econ.) & M.Sc (Health Econ)

+46 73 447 47 27
lisse-lotte.hermansson@medaffcon.se

Linkedin-profiili

Lisse-Lotte started at Medaffcon 1st of October 2024. Previously she was at a Swedish-German company as CSO Chief Scientific Officer, consulting European companies about Nordic health data opportunities and market access. She has a M.Sc (Econ.) from Helsingin School of Economics and a M.Sc (Health Econ) from Karolinska. Additionally a Ph.D student at the University of Turku in Health Economics. She has obtained a long experience from global pharma and medtech. She has lived over 20 years in Sweden.

The current development gives new possibilities to utilise data. With AI we can produce synthetic data and build digital twins that can actually support drug development and support healthcare providers. Innovative solutions are only useful if they are adopted to daily practice.

Old ways of working will vanish and RWD will be acknowledged as an excellent option or support for RCTs. As RWD is enabling more cost-effective evidence generation for new treatments. Treatments need to be more personalised so that the right drugs, diagnostics and devices are used for the right patients at the right time.

Cookies

Experts

Wide-ranging expertise

Life Sciences

Mariann
Lassenius

Kristiina
Pelli

Liisa
Ukkola-Vuoti

Kristiina
Uusi-Rauva

Kai
Kysenius

Bettina
Mannerström

Riikka
Mattila

Outi
Laatikainen

Essi
Havula

Johan
Rehnberg

Health Economics & Market Access

Tanja
Nieminen

Timo
Karvinen

Juulia
Tuominen

Lotta
Jokimies

Annu
Söderholm

Katariina
Autio

Simo
Jääskeläinen

Julia
Salmi

Data Sciences

Iiro
Toppila

Samuli
Tuominen

Johanna
Vikkula

Juhani
Aakko

Olivia
Hölsä

Anna
Anttalainen

Sanaz
Jamalzadeh

Administration

Heikki
Koski

Jarmo
Hahl

Tomi
Vahevaara

Petri
Määttä

Marissa
Vahevaara

Tuuli
Moilanen

Lisse-Lotte
Hermansson

Cookies

Experts

Wide-ranging expertise

Life Sciences

MariannLassenius

KristiinaPelli

LiisaUkkola-Vuoti

KristiinaUusi-Rauva

KaiKysenius

BettinaMannerström

RiikkaMattila

OutiLaatikainen

EssiHavula

JohanRehnberg

Health Economics & Market Access

TanjaNieminen

TimoKarvinen

JuuliaTuominen

LottaJokimies

AnnuSöderholm

KatariinaAutio

SimoJääskeläinen

JuliaSalmi

Data Sciences

IiroToppila

SamuliTuominen

JohannaVikkula

JuhaniAakko

OliviaHölsä

AnnaAnttalainen

SanazJamalzadeh

Administration

HeikkiKoski

JarmoHahl

TomiVahevaara

PetriMäättä

MarissaVahevaara

TuuliMoilanen

Lisse-LotteHermansson

Mariann Lassenius

Kristiina Pelli

Liisa Ukkola-Vuoti

Kristiina Uusi-Rauva

Kai Kysenius

Bettina Mannerström

Riikka Mattila

Outi Laatikainen

Essi Havula

Johan Rehnberg

Tanja Nieminen

Timo Karvinen

Juulia Tuominen

Lotta Jokimies

Annu Söderholm

Katariina Autio

Simo Jääskeläinen

Julia Salmi

Iiro Toppila

Samuli Tuominen

Johanna Vikkula

Juhani Aakko

Olivia Hölsä

Anna Anttalainen

Sanaz Jamalzadeh

Heikki Koski

Jarmo Hahl

Tomi Vahevaara

Petri Määttä

Marissa Vahevaara

Tuuli Moilanen

Lisse-Lotte Hermansson

Mariann
Lassenius

Kristiina
Pelli

Liisa
Ukkola-Vuoti

Kristiina
Uusi-Rauva

Kai
Kysenius

Bettina
Mannerström

Riikka
Mattila

Outi
Laatikainen

Essi
Havula

Johan
Rehnberg

Tanja
Nieminen

Timo
Karvinen

Juulia
Tuominen

Lotta
Jokimies

Annu
Söderholm

Katariina
Autio

Simo
Jääskeläinen

Julia
Salmi

Iiro
Toppila

Samuli
Tuominen

Johanna
Vikkula

Juhani
Aakko

Olivia
Hölsä

Anna
Anttalainen

Sanaz
Jamalzadeh

Heikki
Koski

Jarmo
Hahl

Tomi
Vahevaara

Petri
Määttä

Marissa
Vahevaara

Tuuli
Moilanen

Lisse-Lotte
Hermansson